UVA’s seed fund and corporate venturing unit PharmStandard Ventures featured in topical dry eye syndrome peptide spinout TearSolutions' financing round, taking its total to $21.5m.

Uniseed, Carthona Capital and BridgeLane Group provided the funding for University of Sydney-founded Agerris, which is preparing to commercialise products including robotic farm hand systems.

Catering services marketplace Hungry has now raised $12.5m in total, having added university venture unit James Madison Innovations to its investment consortium.

University of Michigan’s Mints vehicle joined existing investor Intel Capital for SOC producer Movellus’ series A round, which increased the company's overall funding to $10m.

NextGen Jane, which is looking to commercialise reproductive health technology partially developed at Harvard, has received $9m from investors including Harvard-affiliated backers.

Founding investor Mercia Technologies joined fund manager Invesco for the synthetic biology contractor’s latest round, taking its total funding past the $25m mark.

Kyoto University has taken part in an $8.1m series A round for Alphanavi Pharma, which is developing drugs for neuropathic pain that will partly be based on the institution's research.

The series A funding comes after predictive data analytics companies MoBagel went through a resources-only edition of the SkyDeck accelerator last year.

CWRU-licensed NervGen Pharma floated at the top of its range on the TSX Venture Exchange, with the proceeds earmarked to push its lead candidate for spinal cord injury into the clinic.

Oregon Venture Fund and Rogue Venture Partners have both backed University of Oregon's DNA testing services provider NemaMetrix to bring the spinout’s total to $8.5m.